Showing results (1-10 of 714) with videos related to
Sort By:
Pageof 72
European Heart Journal|October 29, 2009
Carotid artery stenting vs. endarterectomyMarco Roffi, Debabrata Mukherjee, Daniel G ClairAmerican Heart Journal|February 3, 2009
Current role of emboli protection devices in percutaneous coronary and vascular interventionsMarco Roffi, Debabrata MukherjeeExpert Opinion on Drug Metabolism & Toxicology|April 13, 2007
Current strategies with high-dose tirofibanDebabrata Mukherjee, Marco RoffiThe Journal of Invasive Cardiology|May 2, 2002
Endovascular treatment of carotid artery aneurysms with stent graftsDebabrata Mukherjee, Marco Roffi, Jay S YadavIndian Heart Journal|January 6, 2009
Current perspectives on coronary revascularization in the diabetic patientMarco Roffi, Michael Brandle, Mark A Robbins, et al.The Journal of Invasive Cardiology|April 2, 2003
Superficial femoral artery occlusion: nitinol stents achieve better flow and reduce the need for medications than balloon angioplasty aloneLeslie Cho, Marco Roffi, Debabrata Mukherjee, et al.The Journal of Invasive Cardiology|April 12, 2013
Superficial femoral artery occlusion: nitinol stents achieve flow and reduce the need for medications better than balloon angioplasty aloneLeslie Cho, Marco Roffi, Debabrata Mukherjee, et al.Annals of Internal Medicine|February 2, 2026
In AF with drug-eluting stent for ≥1 y, NOACs were noninferior to NOAC + clopidogrel for a composite of adverse clinical events at 1 yDebabrata Mukherjee, Annals of Internal Medicine|August 18, 2020
After revascularization for PAD, rivaroxaban reduced vascular events with a small increase in major bleedingDebabrata MukherjeeAnnals of Internal Medicine|September 4, 2023
In HF, with or without PAD, dapagliflozin reduced a composite of worsening HF or CV death and did not increase amputationsDebabrata MukherjeePageof 72